Anebulo Pharmaceuticals Inc (ANEB) financials · $15.3M cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Anebulo Pharmaceuticals Inc (ANEB) $15.3M cap.
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Income | -$9.22M | -$8.31M |
| Net Income | -$8.48M | -$8.20M |
| EPS (Diluted) | -$0.25 | -$0.32 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $12.1M | $4.07M |
| Current Assets | $12.0M | $3.51M |
| Cash & Equivalents | $11.6M | $3.09M |
| Total Liabilities | $487.7K | $260.6K |
| Shareholders' Equity | $11.7M | $3.81M |
| Retained Earnings | -$73.9M | -$65.4M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$6.35M | -$8.09M |
| Financing Cash Flow | $14.9M | -$62.4K |
| Net Change in Cash | $8.53M | -$8.15M |
FAQ
What is ANEB P/E and revenue?
Anebulo Pharmaceuticals Inc (ANEB) $15.3M cap.
What is ANEB revenue?
ANEB income-statement cache has no revenue figure yet.
Is ANEB profitable?
Anebulo Pharmaceuticals Inc last cached net income is -$8.48M (FY2025).
What are ANEB total assets?
Anebulo Pharmaceuticals Inc last cached total assets are $12.1M (FY2025).
What is ANEB free cash flow?
No cached cash-flow row for ANEB yet.
Not investment advice. Cached statements, not a live tape.